Key statistics
On Wednesday, Eledon Pharmaceuticals Inc (2TK:BER) closed at 2.82, 34.29% above the 52 week low of 2.10 set on Oct 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.82 |
---|---|
High | 2.82 |
Low | 2.82 |
Bid | 2.84 |
Offer | 2.94 |
Previous close | 2.66 |
Average volume | 0.00 |
---|---|
Shares outstanding | 59.88m |
Free float | 59.71m |
P/E (TTM) | -- |
Market cap | 204.80m USD |
EPS (TTM) | -0.21 USD |
Data delayed at least 15 minutes, as of Jul 09 2025 07:00 BST.
More ▼
Announcements
- Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
- Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results
- Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
- Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
- Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
- Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference
- Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
- Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
- Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
- Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
More ▼